Cargando…
Blood Targets of Adjuvant Drugs Against COVID19
While waiting for the vaccine and/or the best treatment for COVID19, several drugs have been identified as potential adjuvant drugs to counteract the viral action. Several drugs, in fact, have been suggested for their ancillary antiviral role. Viral proteases and peptidases, may interact with well-k...
Autores principales: | Di Micco, Pierpaolo, Di Micco, Gianluca, Russo, Vincenzo, Poggiano, Maria Rita, Salzano, Ciro, Bosevski, Marijan, Imparato, Michele, Fontanella, Luca, Fontanella, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338832/ https://www.ncbi.nlm.nih.gov/pubmed/32694923 http://dx.doi.org/10.2147/JBM.S256121 |
Ejemplares similares
-
Resolution of Disseminated Intravascular Coagulation in a Patient with COVID-19 and Associated Sepsis—Induced Neutropenia
por: Di Micco, Pierpaolo, et al.
Publicado: (2021) -
In vitro Fertilization Procedures with Embryo Transfer and Their Association with Thrombophilia, Thrombosis and Early Antithrombotic Treatments
por: Di Micco, Pierpaolo, et al.
Publicado: (2020) -
Benign intracranial hypertension associated to blood coagulation derangements
por: De Lucia, Domenico, et al.
Publicado: (2006) -
Mortality in relation to smoking: the British Doctors Study
por: Di Cicco, Maria Elisa, et al.
Publicado: (2016) -
Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)